Cogent Biosciences (COGT) Retained Earnings (2017 - 2021)
Historic Retained Earnings for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to -$246.1 million.
- Cogent Biosciences' Retained Earnings fell 3135.0% to -$246.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$246.1 million, marking a year-over-year decrease of 3135.0%. This contributed to the annual value of -$198.7 million for FY2020, which is 6038.16% down from last year.
- Cogent Biosciences' Retained Earnings amounted to -$246.1 million in Q3 2021, which was down 3135.0% from -$227.0 million recorded in Q2 2021.
- Over the past 5 years, Cogent Biosciences' Retained Earnings peaked at -$51.3 million during Q4 2017, and registered a low of -$246.1 million during Q3 2021.
- Over the past 5 years, Cogent Biosciences' median Retained Earnings value was -$125.0 million (recorded in 2019), while the average stood at -$135.6 million.
- In the last 5 years, Cogent Biosciences' Retained Earnings tumbled by 7931.59% in 2018 and then tumbled by 2022.74% in 2020.
- Over the past 5 years, Cogent Biosciences' Retained Earnings (Quarter) stood at -$51.3 million in 2017, then tumbled by 79.32% to -$92.1 million in 2018, then tumbled by 34.58% to -$123.9 million in 2019, then tumbled by 60.38% to -$198.7 million in 2020, then fell by 23.86% to -$246.1 million in 2021.
- Its Retained Earnings was -$246.1 million in Q3 2021, compared to -$227.0 million in Q2 2021 and -$210.4 million in Q1 2021.